DocGo approves extension of expiration date of share repurchase program

According to a regulatory filing, on December 20, 2024, the board of directors of DocGo (DCGO) approved an extension of the expiration date of the company’s current share repurchase program from December 31, 2024 to June 30, 2025. As previously disclosed, pursuant to the Repurchase Program, the company may purchase up to $26M in shares of the company’s common stock. Other than the extension of the program’s expiration date, no changes were made to the Repurchase Program. Under the terms of the Repurchase Program, as extended, the company may continue to purchase shares of its common stock on a discretionary basis from time to time through open market repurchases or privately negotiated transactions or through other means, including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs, in each case, during an “open window” and when the company does not possess material non-public information.